Référence du document

SWD(2024)0049  
Phasing out of derogations for certain medicinal products in Cyprus, Ireland, and Malta. Report  
Basic information  

SWD(2024)0049

Commission working document (SWD)


Subject
4.20.01 Medicine, diseases
4.20.02.06 Clinical practice and experiments
4.20.04 Pharmaceutical products and industry

Geographical area
Ireland
Malta
Cyprus

Status

Preparatory phase in Parliament

 

Key players  
Key events  
04/03/2024
Internal referral to parliamentary committee(s)
Technical information  
Information document reference
SWD(2024)0049
Type of document
Commission working document (SWD)
Stage reached
Preparatory phase in Parliament
Documentation gateway  
  • European Commission 
    Commission working document (SWD)
     
    SWD(2024)0049
    01/03/2024
     
     
  • All 
    Commission working document (SWD)
       
    SWD(2024)0049
    01/03/2024